recommended from changing the lifestyle, with regular practice of aerobic physical activity associated with dietary re-education in a guided way, to the use of medication, being essential to control the associated metabolic comorbidities, such as obesity, dyslipidemia, insulin resistance and type 211 diabetes mellitus.

Among the rare forms of gastritis associated with infections by specific agents, candidiasis appears as the most frequent, when considering fungal microorganisms. After the advent of the acquired immunodeficiency syndrome (SIDA), so-called opportunistic infections have become more and more frequent, although they remain rare entities when observed in patients without compromising the immune system.

Objective: To verify the role of the FODMAP's restrictive diet in the treatment and control of irritable bowel syndrome. Methods:The most relevant studies originally published in English, Portuguese and Spanish were analyzed using the MEDLINE (National Library of Medicine and National Institutes of Health) and SciELO databases as reference. In order to select the studies with the greatest scientific evidence, we only contemplate clinical trials and review studies. The search strategy used the following keywords: "irritable bowel syndrome" and "FODMAP's restricted diet". To identify the designs of the studies, the following terms were used: clinical trials. Results: Initially, 117 studies were identified involving irritable bowel syndrome and the Foodmap diet. However, after applying the Clinical Trials filters, 10 studies were found. After reading the articles found and excluding them from the abstracts, 5 articles were selected involving the theme for analysis and inclusion in the scope of this review. Conclusion:The restricted diet in FODMAPs proved to be very effective in improving general and specific symptoms of irritable bowel syndrome, especially abdominal pain, bloating and diarrhea.